These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16990004)

  • 1. Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase.
    Ding Y; Smith KL; Varaprasad CV; Chang E; Alexander J; Yao N
    Bioorg Med Chem Lett; 2007 Feb; 17(3):841-5. PubMed ID: 16990004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5888-91. PubMed ID: 16934455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
    Talele TT; Arora P; Kulkarni SS; Patel MR; Singh S; Chudayeu M; Kaushik-Basu N
    Bioorg Med Chem; 2010 Jul; 18(13):4630-8. PubMed ID: 20627595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.
    Yan S; Larson G; Wu JZ; Appleby T; Ding Y; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):63-7. PubMed ID: 17049849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
    Zhao C; Wang Y; Ma S
    Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides.
    Krueger AC; Madigan DL; Jiang WW; Kati WM; Liu D; Liu Y; Maring CJ; Masse S; McDaniel KF; Middleton T; Mo H; Molla A; Montgomery D; Pratt JK; Rockway TW; Zhang R; Kempf DJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3367-70. PubMed ID: 16650764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
    Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Development of Metal-Catalyzed Coupling Reactions in the Synthesis of Dasabuvir, an HCV-Polymerase Inhibitor.
    Barnes DM; Shekhar S; Dunn TB; Barkalow JH; Chan VS; Franczyk TS; Haight AR; Hengeveld JE; Kolaczkowski L; Kotecki BJ; Liang G; Marek JC; McLaughlin MA; Montavon DK; Napier JJ
    J Org Chem; 2019 Apr; 84(8):4873-4892. PubMed ID: 30629443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives.
    Wang G; He Y; Sun J; Das D; Hu M; Huang J; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4476-9. PubMed ID: 19502055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isothiazoles as active-site inhibitors of HCV NS5B polymerase.
    Yan S; Appleby T; Gunic E; Shim JH; Tasu T; Kim H; Rong F; Chen H; Hamatake R; Wu JZ; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):28-33. PubMed ID: 17049853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives.
    Wang G; Zhang L; Wu X; Das D; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Buckman BO; Kossen K; Seiwert SD; Beigelman L
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4484-7. PubMed ID: 19497737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold.
    Al-Ansary GH; Ismail MA; Abou El Ella DA; Eid S; Abouzid KA
    Eur J Med Chem; 2013 Oct; 68():19-32. PubMed ID: 23933047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors.
    Hendricks RT; Fell JB; Blake JF; Fischer JP; Robinson JE; Spencer SR; Stengel PJ; Bernacki AL; Leveque VJ; Le Pogam S; Rajyaguru S; Najera I; Josey JA; Harris JR; Swallow S
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3637-41. PubMed ID: 19447623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake RK; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1991-5. PubMed ID: 17276060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
    Malancona S; Donghi M; Ferrara M; Martin Hernando JI; Pompei M; Pesci S; Ontoria JM; Koch U; Rowley M; Summa V
    Bioorg Med Chem; 2010 Apr; 18(8):2836-48. PubMed ID: 20363140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.
    Gopalsamy A; Chopra R; Lim K; Ciszewski G; Shi M; Curran KJ; Sukits SF; Svenson K; Bard J; Ellingboe JW; Agarwal A; Krishnamurthy G; Howe AY; Orlowski M; Feld B; O'Connell J; Mansour TS
    J Med Chem; 2006 Jun; 49(11):3052-5. PubMed ID: 16722622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based library design in efficient discovery of novel inhibitors.
    Yan S; Selliah R
    Methods Mol Biol; 2011; 685():175-90. PubMed ID: 20981524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; Omar FA
    Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
    LaPorte MG; Draper TL; Miller LE; Blackledge CW; Leister LK; Amparo E; Hussey AR; Young DC; Chunduru SK; Benetatos CA; Rhodes G; Gopalsamy A; Herbertz T; Burns CJ; Condon SM
    Bioorg Med Chem Lett; 2010 May; 20(9):2968-73. PubMed ID: 20347591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.
    Yang H; Hendricks RT; Arora N; Nitzan D; Yee C; Lucas MC; Yang Y; Fung A; Rajyaguru S; Harris SF; Leveque VJ; Hang JQ; Pogam SL; Reuter D; Tavares GA
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4614-9. PubMed ID: 20584604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.